002275.SZ
桂林三金
SZSE · Healthcare · C 制造业 · CN
CNY 12.57
−4.99%Aug 3, 2026, 09:00 UTC
Guilin Sanjin's wholly-owned subsidiary Hunan Sanjin was provisionally selected in the 12th national centralized drug procurement for lamotrigine tablets, with the procurement period running until December 31, 2029.
Source:Jul 27, 2026, 09:19 UTC
Guilin Sanjin Pharmaceutical Co., Ltd. provided guarantees totaling 60 million yuan for its wholly-owned subsidiaries Baochuan Bio and Baifan Bio to increase their credit lines with Xiamen International Bank Shanghai Branch.
Source: